ClinicalTrials.gg
Sign In
RecruitingNCT06711783VISANUpdated May 1, 2026

Treatment of Adolescent Anorexia Nervosa

An interventional study of Family based therapy in Eating Disorders, sponsored by Region Örebro County. Recruiting at 1 site in Sweden. Open to participants aged 11 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-05-01.

Primary conditionAnorexia NervosaRegistry: Feeding and Eating DisordersReclassifiedWhy we changed it
Registry
Feeding and Eating Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Anorexia Nervosa
Why
  1. The study's title name Anorexia Nervosa, a narrower term within Feeding and Eating Disorders.
Confidence
High: the new condition is named in the study's own title. Of 46 hand-checked studies reclassified this way, 72% were exactly right and 89% in the right disease family; the registry's first term was right for 4% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Region Örebro County · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Aug 2024, registered Nov 2024).
  • Started Aug 2024; still recruiting 2 years 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Not applicable
Ages
11 Years to 17 Years
Sex
All
01

Study summary

VISAN is a naturalistic study of family based treatment of Anorexia nervosa in adolescnet girls.

02

Conditions studied

  • Eating Disorders

Browse trials for

Keywords

  • anorexia nervosa
03

In context

Anorexia Nervosa Reclassified

469 studies on the registry are indexed under Anorexia Nervosa; 127 are open to participants now.

This study's planned enrollment of 60 is above the median of 46 across 313 interventional studies indexed under Anorexia Nervosa.

Browse Anorexia Nervosa studies →

Lead sponsor

Region Örebro County is the lead sponsor of 124 studies on the registry; 29 are open to participants now.

Browse Region Örebro County studies →

Compared within Anorexia Nervosa, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Feeding and Eating Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
11 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Having been diagnosed with f500 or f501 and being planned for family based therapy at the unit.

Exclusion criteria

Exclusion Criteria:

  • being subjected to care by the social welfare system
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Family based treatment

    Family based treatment including the whole chain of care, such as day care and in patiant care when necessary. The interventions includes consultation with dietician, psyciotherapist, LEAP-Y and Skills training based on an individual plan.

    Behavioral: Family based therapy

Interventions

  • BehavioralFamily based therapy

    Family based therapy following the Maudsley model

06

What researchers measure

Primary outcomes

  1. Remission

    No longer fulfilling criteria for an eating disorder

    Time frame: End of treatment (assessed up to 1 year)

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06711783
Lead sponsor
Region Örebro County
Responsible party
Sponsor
First posted
Dec 2, 2024
Start date
Aug 1, 2024
Primary completion
Dec 31, 2028 (estimated)
Completion
Dec 31, 2029 (estimated)
Last update
May 1, 2026

Study contacts

Sanna Gustafsson A Gustafsson, Ass prof
Contact
sanna.aila-gustafsson@regionorebrolan.se
+46722495986

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Anorexia Nervosa →

Other studies from this sponsor

Region Örebro County →

Start the discussion